Table GPSurvey-6. Last month prevalence of drug use (percentage) among young adults (15-34 years old) in nationwide surveys among the general population

	Country and geographical area	Ref.	Year	Sample size	Cannabis	Cocaine	Amphet-amines	Ecstasy	Hallucin-ogens	LSD

	Belgium
	Vlanderen (Brussels excluded)	⁽¹⁾	1994	na
	French Community	⁽²⁾	1996-97	508
	French Community	⁽³⁾	1998-99	504
	French Community	⁽⁴⁾	2000	282	7.3
	National coverage (Flemish, Wallon and Brussels region)	⁽⁵⁾	2001	2758	5.9		0.6
	Czech Republic
	National	⁽¹⁾	2002	1002
	Denmark
	National	⁽¹⁾	1990	na
	National	⁽²⁾	1994	2521
	National	⁽³⁾	2000	4141	5.6	0.6	0.9	0.4	0.5	0.1
	Germany
	Western Germany	⁽¹⁾	1990	19207
	East Germany	⁽²⁾	1990	na
	Old Länder (W. Germany) and New Länder (E. Germany)	⁽³⁾	1995	3157	6.1	0.9	0.7	1.2	0.4
	Old Länder (W. Germany) and New Länder (E. Germany)	⁽⁴⁾	1997	3058	6.0	0.5	0.4	0.7	0.1
	National	⁽⁵⁾	2000	3017	7.2	0.5	0.5	0.7	0.4	0.2
	Estonia
	National	⁽¹⁾	1998	804	1.0
	Greece
	Athens	⁽¹⁾	1993	na
	Greece except Aegean and Ionian Islands	⁽²⁾	1998	2014	4.6	0.4	0.0	0.1	0.2
	Spain
	National	⁽¹⁾	1995	5813
	National	⁽²⁾	1997	6898	7.3	1.46	0.46	0.4	0.44
	National	⁽³⁾	1999	6293	7.9	1.4	0.4	0.8	0.3
	National	⁽⁴⁾	2001	6915	11.9	2.4	1.1	1.5	0.4
	France
	National	⁽¹⁾	1992	373
	Metropolitan France	⁽²⁾	1995	756
	National	⁽³⁾	1999	753
	National	⁽⁴⁾	2000	4749	9.0	0.2	0.1	0.2		0.1
	Metropolitan France	⁽⁵⁾	2002	730
	Ireland
	National	⁽¹⁾	1998	na	9.7
	National	⁽²⁾	1998	318
	National	⁽³⁾	2000	404
	National	⁽⁴⁾	2002-03		4.4	0.7	0.3	0.6		0.0
	Italy
	National	⁽¹⁾	2001	3698	6.6	1.1	0.0	0.2	0.2	0.0
	Latvia
	National	⁽¹⁾	2003		3.7	0.1	1.1	0.6	0.6	0.6
	Luxembourg
	National ( representative regional communities)	⁽¹⁾	1998	na	5.6	0.3		0.0	1.3	0.0
	Hungary
	National	⁽¹⁾	2001	790	2.6	0.1	0.5	0.4	0.1	0.1
	Netherlands
	National	⁽¹⁾	1997-98	9090	5.1	0.5	0.3	0.7	0.3
	National	⁽²⁾	2000-01	6687	7.0	0.9	0.5	1.3	0.2	0.0
	Poland
	National	⁽¹⁾	2002		2.7	0.1	0.5	0.4	0.1	0.1
	Portugal
	National	⁽¹⁾	2001	6406	4.4	0.3	0.1	0.4		0.1
	Slovakia
	National	⁽¹⁾	2002	1147	5.9	0.0	0.2	0.2	0.0
	Finland			1000
	National	⁽¹⁾	1992	974	0.8
	National	⁽²⁾	1996	615	1.6
	National	⁽³⁾	1998	1240	2.2	0.2	0.2	0.4	0.1
	National	⁽⁴⁾	2000		1.4	0.2	0.2	0.4		0.2
	National	⁽⁵⁾	2002		2.9	0.1	0.5	0.2
	Sweden
	National	⁽¹⁾	1994	310
	National	⁽²⁾	1996	476
	National	⁽³⁾	1998	542	0.4	0.0	0.0	0.0
	National	⁽⁴⁾	2000	575	0.1	0.0	0.0	0.0		0.0
	United Kingdom
	England and Wales	⁽¹⁾	1994	4329	9.8	0.3	2.2	0.8	1.1	0.9
	England and Wales	⁽²⁾	1996	4720	10.2	0.5	3.2	1.5	0.8	0.6
	England and Wales	⁽³⁾	1998	4112	11.7	0.8	2.9	1.2	0.2	0.2
	England and Wales	⁽⁴⁾	2000	4910	12.3	1.6	1.9	2.1	0.5	0.3
	England and Wales	⁽⁵⁾	2001-02	9006	12.1	1.8	1.3	2.3	0.5	0.2
	England and Wales	⁽⁶⁾	2002-03	8520	12.4	1.9	1.2	1.8	0.4	0.2
	Northern Ireland	⁽⁷⁾	2002-03	na	5.4	0.2	0.4	1.1	0.0	0.0
	Norway
	National	⁽¹⁾	1999	794	4.5	0.1	0.4	0.6

Notes:
This table aims to present national surveys. Exceptionally some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimaties for whole countries (or big regions with urban and rural areas). Athens was included as reference point for 1993 survey.
In surveys with small sample sizes results should be interpreted with caution.
Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.
For methods and definitions see [Methods and definitions - Prevalence and patterns of drug use in the general population].
For survey methods see [Table GPSurvey-1 Part (ii) Survey methods].

Sources: See [Table GPSurvey-1 Part(iii) Sources].

Download